Company: LGNZZ
Filing Date: 2025-07-03
Form Type: 3
Source: 0000950170-25-093585
Chunk: 1

Company: LIGAND PHARMACEUTICALS INC
Filing Date: 2025-07-03
Form: 3
Chunk 1
---
 |                                                   $10.00 | N/A                                                                         | N/A                                                    | N/A                                                      | N/A                                                   | N/A | N/A | [F1] - [F1] | Common Stock - 1,800,000 | N/A | N/A | D |

| ** Signature of Reporting Person                                                         
 /s/ /s/ Octavio Espinoza, Chief Financial Officer of Ligand Pharmaceuticals Incorporated | Date       
 07/02/2025 |

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. 
 Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.